EcoDrugPlus

Adrenoceptor Alpha 1d

Ensembl ID : ENSCLAG00000010677
Gene Symbol: ADRA1D
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSCLAG00000006230
Gene Symbol: ADRA2A
2 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCLAG00000007633
Gene Symbol: ADRA2B
3 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSCLAG00000017769
Gene Symbol: ADRB2
2 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSCLAG00000005285
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCLAG00000013330
Gene Symbol: AGER
2 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSCLAG00000015753
Gene Symbol: ADH5
2 Cross references
403 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCLAG00000012329
Gene Symbol: AKR1B1
2 Cross references
426 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCLAG00000011247
Gene Symbol: GAA
3 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCLAG00000001431
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSCLAG00000016573
Gene Symbol: AOC3
2 Cross references
326 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSCLAG00000013265
Gene Symbol: APCS
2 Cross references
402 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).